<?xml version="1.0" encoding="UTF-8"?>
<p>Finally, the future development of the ATMP sector also depends on state-of-the-art technologies, particularly in the field of quality control. However, some of these new technologies may be very expensive, especially for EU member states with lower gross domestic product (GDP) rates. Therefore, the added value of these technologies needs to be reassessed at national level so that healthcare policy can respond to the safety and the quality of the ATMPs [
 <xref rid="R20" ref-type="bibr">20</xref>].
</p>
